OpenURL Connection Search

Select item for more details and to access through your institution.

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
Published in:
Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0631-3
By:
- Chen, Robert W.;
- Palmer, Joycelynne M.;
- Tomassetti, Sarah;
- Popplewell, Leslie L.;
- Alluin, Jessica;
- Chomchan, Pritsana;
- Nademanee, Auayporn P.;
- Siddiqi, Tanya;
- Tsai, Ni-Chun;
- Chen, Lu;
- Zuo, Fay;
- Abary, Rosemarie;
- Cai, Ji-lian;
- Herrera, Alex F.;
- Rossi, John J.;
- Rosen, Steven T.;
- Forman, Stephen J.;
- Kwak, Larry W.;
- Holmberg, Leona A.
Publication type:
Article
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Published in:
British Journal of Haematology, 2014, v. 165, n. 4, p. 510, doi. 10.1111/bjh.12780
By:
- Wang, Michael;
- Popplewell, Leslie L.;
- Collins, Robert H.;
- Winter, Jane N.;
- Goy, Andre;
- Kaminski, Mark S.;
- Bartlett, Nancy L.;
- Johnston, Patrick B.;
- Lister, John;
- Fanning, Suzanne R.;
- Tuscano, Joseph M.;
- Beck, J. Thaddeus;
- Kaya, Hakan;
- Robeva, Anna;
- Fan, Jenna;
- Klimovsky, Judith;
- Cheung, Wing;
- Cherfi, Azzeddine;
- O'Connor, Owen A.
Publication type:
Article
INCORPORATION of MILK PROTEINS HARVESTED BY DIRECT ACIDIFICATION INTO PROCESS CHEESE PRODUCTS.
Published in:
Journal of Food Process Engineering, 1989, v. 11, n. 3, p. 203, doi. 10.1111/j.1745-4530.1989.tb00030.x
By:
- POPPLEWELL, L. M.;
- ROSENAU, J. R.
Publication type:
Article
Synthesis and anti-plasmodial activity of 8β, 13β-dihydroxypodocarpane derivatives.
Published in:
Journal of Chemical Research, 2011, v. 35, n. 1, p. 18, doi. 10.3184/174751911X12964930076658
By:
- Young, Ryan M.;
- Popplewell, Wendy L.;
- Caira, Mino R.;
- Van Zyl, Robyn L.;
- Davies-Coleman, Michael T.
Publication type:
Article
A phase II trial of BAY 43-9006 (sorafenib) ( NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.
Published in:
Cancer Medicine, 2014, v. 3, n. 5, p. 1275, doi. 10.1002/cam4.276
By:
- Srkalovic, Gordan;
- Hussein, Mohamad A.;
- Hoering, Antje;
- Zonder, Jeffrey A.;
- Popplewell, Leslie L.;
- Trivedi, Harsha;
- Mazzoni, Sandy;
- Sexton, Rachel;
- Orlowski, Robert Z.;
- Barlogie, Bart
Publication type:
Article
Calculating the beta function from three common particle size distributions.
Published in:
AIChE Journal, 1989, v. 35, n. 2, p. 347, doi. 10.1002/aic.690350226
By:
- Popplewell, L. M.;
- Peleg, M.
Publication type:
Article
Quantitative characterization of the particle size distributions of instant coffee during mechanical attrition
Published in:
Journal of Food Science (Wiley-Blackwell), 1988, v. 53, n. 3, p. 877
By:
- Campanella, O. H.;
- Peleg, M.;
- Popplewell, L. M.
Publication type:
Article
Elongational viscosity measurements of melting American process cheese
Published in:
Journal of Food Science (Wiley-Blackwell), 1987, v. 52, n. 5, p. 1249, doi. 10.1111/j.1365-2621.1987.tb14054.x
By:
- Campanella, O. H.;
- Popplewell, L. M.;
- Peleg, M. Peleg;
- Rosenau, J. R.
Publication type:
Article
Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML.
Published in:
2010
By:
- Huang, Q.;
- Popplewell, L.;
- Lu, Y.;
- Slovak, M. L.;
- Forman, S. J.
Publication type:
Letter
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.
Published in:
Bone Marrow Transplantation, 2006, v. 37, n. 9, p. 825, doi. 10.1038/sj.bmt.1705339
By:
- Sahebi, F.;
- Spielberger, R.;
- Kogut, N. M.;
- Fung, H.;
- Falk, P. M.;
- Parker, P.;
- Krishnan, A.;
- Rodriguez, R.;
- Nakamura, R.;
- Nademanee, A.;
- Popplewell, L.;
- Frankel, P.;
- Ruel, C.;
- Tin, R.;
- Ilieva, P.;
- Forman, S. J.;
- Somlo, G.
Publication type:
Article
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 11, p. 1123, doi. 10.1038/sj.bmt.1704493
By:
- Rodriguez, R.;
- Parker, P.;
- Nademanee, A.;
- Smith, D.;
- O'Donnell, M. R.;
- Stein, A.;
- Snyder, D. S.;
- Fung, H. C.;
- Krishnan, A. Y.;
- Popplewell, L.;
- Cohen, S.;
- Somlo, G.;
- Angelopoulou, M.;
- Al-Kadhimi, Z.;
- Falk, P. M.;
- Spielberger, R.;
- Kogut, N.;
- Sahebi, F.;
- Senitzer, D.;
- Slovak, M.
Publication type:
Article
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 724, doi. 10.1016/j.clml.2024.05.017
By:
- Kambhampati, Swetha;
- Mei, Matthew G.;
- Chen, Lu;
- Puverel, Sandrine;
- Chen, Robert;
- Popplewell, Leslie L.;
- Nikolaenko, Liana;
- Peters, Lacolle;
- Armenian, Saro;
- Kwak, Larry W.;
- Rosen, Steven T.;
- Forman, Stephen J.;
- Herrera, Alex F.
Publication type:
Article
PD-1 Blockade After Avelumab in Relapsed/Refractory Classical Hodgkin Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. e893, doi. 10.1016/j.clml.2022.06.004
By:
- Kambhampati, Swetha;
- Mei, Matthew G.;
- Godfrey, James;
- Siddiqi, Tanya;
- Salhotra, Amandeep;
- Chen, Robert;
- Smith, Eileen;
- Popplewell, Leslie L.;
- Herrera, Alex F.
Publication type:
Article
Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e443, doi. 10.1016/j.clml.2021.12.010
By:
- Palomba, M. Lia;
- Till, Brian G.;
- Park, Steven I.;
- Morschhauser, Franck;
- Cartron, Guillaume;
- Marks, Reinhard;
- Shivhare, Mahesh;
- Hong, Wan-Jen;
- Raval, Aparna;
- Chang, Alice C.;
- Penuel, Elicia;
- Popplewell, Leslie L.
Publication type:
Article
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.
Published in:
2020
By:
- Zelenetz, Andrew D.;
- Popplewell, Leslie L.;
- Noy, Ariela;
- Horner, Thierry J.;
- Lin, Thomas S.;
- Donnelly, Gerard;
- Sgouros, George;
- Rijo, Ivelise;
- Divgi, Chaitanya R.
Publication type:
journal article
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.
Published in:
Leukemia (08876924), 2013, v. 27, n. 5, p. 1139, doi. 10.1038/leu.2012.311
By:
- VanderWalde, A M;
- Sun, C-L;
- Laddaran, L;
- Francisco, L;
- Armenian, S;
- Berano-Teh, J;
- Wong, F L;
- Popplewell, L;
- Somlo, G;
- Stein, A S;
- Nademanee, A;
- Krishnan, A;
- Kogut, N;
- Forman, S J;
- Bhatia, S
Publication type:
Article
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.
Published in:
2013
By:
- Vanderwalde, A M;
- Sun, C-L;
- Laddaran, L;
- Francisco, L;
- Armenian, S;
- Berano-Teh, J;
- Wong, F L;
- Popplewell, L;
- Somlo, G;
- Stein, A S;
- Nademanee, A;
- Krishnan, A;
- Kogut, N;
- Forman, S J;
- Bhatia, S
Publication type:
journal article
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia.
Published in:
2011
By:
- Kirschbaum, M H;
- Synold, T;
- Stein, A S;
- Tuscano, J;
- Zain, J M;
- Popplewell, L;
- Karanes, C;
- O'Donnell, M R;
- Pulone, B;
- Rincon, A;
- Wright, J;
- Frankel, P;
- Forman, S J;
- Newman, E M
Publication type:
journal article
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.
Published in:
2011
By:
- Scuto, A.;
- Krejci, P.;
- Popplewell, L.;
- Wu, J.;
- Kujawski, M.;
- Kowolik, C.;
- Xin, H.;
- Chen, L.;
- Wang, Y.;
- Kretzner, L.;
- Yu, H.;
- Wilcox, W. R.;
- Yen, Y.;
- Forman, S.;
- Jove, R.
Publication type:
journal article
High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Published in:
Leukemia (08876924), 2003, v. 17, n. 6, p. 1091, doi. 10.1038/sj.leu.2402918
By:
- Ishizawa, S;
- Slovak, M L;
- Popplewell, L;
- Bedell, V;
- Wrede, J E;
- Carter, N H;
- Snyder, D S;
- Arber, D A
Publication type:
Article
DURABLES RESPONSES WITH ANTI‐CD19 ALLOGENEIC CAR T ALLO‐501/501A IN PHASE 1 TRIALS OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (R/R LBCL).
Published in:
Hematological Oncology, 2023, v. 41, p. 85, doi. 10.1002/hon.3163_48
By:
- Locke, F. L.;
- Lekakis, L.;
- Eradat, H.;
- Munoz, J.;
- Tees, M.;
- de Vos, S.;
- Nath, R.;
- Stevens, D.;
- Malik, S.;
- Popplewell, L.;
- Hamadani, M.;
- Oluwole, O.;
- Perales, M.;
- Miklos, D.;
- Fisher, P.;
- Goyal, L.;
- Navale, L.;
- Kaufman, G.;
- Kai, K.;
- Balakumaran, A.
Publication type:
Article
Real‐World Early Outcomes of Axicabtagene Ciloleucel for Relapsed or Refractory (R/R) Follicular Lymphoma (FL).
Published in:
Hematological Oncology, 2023, v. 41, p. 375, doi. 10.1002/hon.3164_271
By:
- Jacobson, C.;
- Hemmer, M. T.;
- Hu, Z.;
- Frank, M.;
- Popplewell, L.;
- Ahmed, N.;
- Lin, Y.;
- Best, T.;
- Beygi, S.;
- Miao, H.;
- Fu, C.;
- Sun, F.;
- Xu, H.;
- Pasquini, M. C.
Publication type:
Article
PHASE I STUDY OF THE CD19/CD3 HALF‐LIFE EXTENDED BITE<sup>®</sup> MOLECULE AMG 562 IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.87_2881
By:
- Mead, M. D.;
- Popplewell, L. L.;
- Subklewe, M.;
- Ghobadi, A.;
- Kuruvilla, J.;
- Kimball, A.;
- Tuglus, C.;
- Agarwal, S.;
- Stieglmaier, J.
Publication type:
Article
EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.85_2879
By:
- Schuster, S. J.;
- Dickinson, M.;
- Dreyling, M.;
- Martinez‐Lopez, J.;
- Kolstad, A.;
- Butler, J.;
- Ghosh, M.;
- Popplewell, L.;
- Chavez, J. C.;
- Bachy, E.;
- Kato, K.;
- Harigae, H.;
- Kersten, M. José;
- Andreadis, C.;
- Riedell, P. A.;
- Abdelhady, A.;
- Zia, A.;
- Morisse, M. C.;
- Fowler, N. H.;
- Thieblemont, C.
Publication type:
Article
THE COMBINATION OF VENETOCLAX, LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA INDUCES HIGH RESPONSE RATES AND MRD UNDETECTABILITY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.61_2879
By:
- Phillips, T. J.;
- Bond, D.;
- Devata, S.;
- Danilov, A.;
- Herrera, A.;
- Maddocks, K.;
- Wilcox, R.;
- Karimi, Y.;
- Carty, S.;
- Kaminski, M.;
- Popplewell, L.
Publication type:
Article
PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.178_2880
By:
- Fowler, N. H.;
- Dickinson, M.;
- Martinez‐Lopez, J.;
- Kolstad, A.;
- Schuster, S. J.;
- Dreyling, M.;
- Ghosh, M.;
- Harigae, H.;
- Kersten, M. José;
- Bachy, E.;
- Popplewell, L.;
- Chavez, J. C.;
- Ho, P. J.;
- Butler, J.;
- Kato, K.;
- von Tresckow, B.;
- Ferreri, A. J. M.;
- Simón, J. A. P.;
- Patten, P. E. M.;
- Andreadis, C.
Publication type:
Article
ELARA: A PHASE 2 TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN ADULT PATIENTS WITH REFRACTORY/RELAPSED FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 559, doi. 10.1002/hon.6_2632
By:
- Dickinson, M.;
- Popplewell, L.;
- Kolstad, A.;
- Ho, P.J.;
- Teshima, T.;
- Dreyling, M.;
- Schuster, S.;
- Thieblemont, C.;
- Ghosh, M.;
- Riedell, P.;
- Yateman, N.;
- Lehnhoff, K.;
- Lawniczek, T.;
- Pacaud, L.;
- Fowler, N.
Publication type:
Article
THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 89, doi. 10.1002/hon.57_2629
By:
- Advani, R.;
- Bartlett, N.L.;
- Smith, S.M.;
- Roschewski, M.;
- Popplewell, L.;
- Flinn, I.;
- Collins, G.;
- Ghosh, N.;
- LaCasce, A.;
- Asch, A.;
- Kline, J.;
- Kesevan, M.;
- Tran, T.;
- Lynn, J.;
- Huang, J.;
- Agoram, B.;
- Volkmer, J.;
- Takimoto, C.H.;
- Chao, M.P.;
- Mehta, A.
Publication type:
Article
SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB IN COMBINATION WITH TAZEMETOSTAT IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 517, doi. 10.1002/hon.203_2631
By:
- Palomba, M.L.;
- Cartron, G.;
- Popplewell, L.;
- Ribrag, V.;
- Westin, J.;
- Chitra, S.;
- Huw, L.;
- Newberry, K.;
- Raval, A.;
- Xu, J.;
- Morschhauser, F.
Publication type:
Article
MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 507, doi. 10.1002/hon.190_2631
By:
- Shouse, G.P.;
- Xue, T.;
- Herrera, A.;
- Siddiqi, T.;
- Zain, J.;
- Popplewell, L.;
- Forman, S.;
- Budde, E.
Publication type:
Article
A FIRST‐IN‐HUMAN STUDY OF A HALF‐LIFE EXTENDED CD19‐TARGETING BiTE IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA OR FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 566, doi. 10.1002/hon.14_2632
By:
- Popplewell, L.;
- Verhoef, G.;
- Kuruvilla, J.;
- Tuglus, C.;
- Kischel, R.;
- Stieglmaier, J.;
- Ghobadi, A.
Publication type:
Article
PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 293, doi. 10.1002/hon.102_2630
By:
- Herrera, A.F.;
- Chen, R.;
- Palmer, J.;
- Tsai, N.;
- McBride, K.;
- Song, J.;
- Mei, M.;
- Zain, J.;
- Nikolaenko, L.;
- Popplewell, L.;
- Nademanee, A.;
- Rosen, S.;
- Kwak, L.;
- Lee, H.;
- Forman, S.
Publication type:
Article
ELARA: A PHASE 2 TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN ADULT PATIENTS WITH REFRACTORY/RELAPSED FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 559, doi. 10.1002/hon.6_2632
By:
- Dickinson, M.;
- Popplewell, L.;
- Kolstad, A.;
- Ho, P.J.;
- Teshima, T.;
- Dreyling, M.;
- Schuster, S.;
- Thieblemont, C.;
- Ghosh, M.;
- Riedell, P.;
- Yateman, N.;
- Lehnhoff, K.;
- Lawniczek, T.;
- Pacaud, L.;
- Fowler, N.
Publication type:
Article
THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 89, doi. 10.1002/hon.57_2629
By:
- Advani, R.;
- Bartlett, N.L.;
- Smith, S.M.;
- Roschewski, M.;
- Popplewell, L.;
- Flinn, I.;
- Collins, G.;
- Ghosh, N.;
- LaCasce, A.;
- Asch, A.;
- Kline, J.;
- Kesevan, M.;
- Tran, T.;
- Lynn, J.;
- Huang, J.;
- Agoram, B.;
- Volkmer, J.;
- Takimoto, C.H.;
- Chao, M.P.;
- Mehta, A.
Publication type:
Article
SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB IN COMBINATION WITH TAZEMETOSTAT IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 517, doi. 10.1002/hon.203_2631
By:
- Palomba, M.L.;
- Cartron, G.;
- Popplewell, L.;
- Ribrag, V.;
- Westin, J.;
- Chitra, S.;
- Huw, L.;
- Newberry, K.;
- Raval, A.;
- Xu, J.;
- Morschhauser, F.
Publication type:
Article
MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 507, doi. 10.1002/hon.190_2631
By:
- Shouse, G.P.;
- Xue, T.;
- Herrera, A.;
- Siddiqi, T.;
- Zain, J.;
- Popplewell, L.;
- Forman, S.;
- Budde, E.
Publication type:
Article
A FIRST‐IN‐HUMAN STUDY OF A HALF‐LIFE EXTENDED CD19‐TARGETING BiTE IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA OR FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 566, doi. 10.1002/hon.14_2632
By:
- Popplewell, L.;
- Verhoef, G.;
- Kuruvilla, J.;
- Tuglus, C.;
- Kischel, R.;
- Stieglmaier, J.;
- Ghobadi, A.
Publication type:
Article
PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 293, doi. 10.1002/hon.102_2630
By:
- Herrera, A.F.;
- Chen, R.;
- Palmer, J.;
- Tsai, N.;
- McBride, K.;
- Song, J.;
- Mei, M.;
- Zain, J.;
- Nikolaenko, L.;
- Popplewell, L.;
- Nademanee, A.;
- Rosen, S.;
- Kwak, L.;
- Lee, H.;
- Forman, S.
Publication type:
Article
A PHASE IB STUDY EVALUATING THE SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB COMBINED WITH OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2017, v. 35, p. 137, doi. 10.1002/hon.2437_126
By:
- Palomba, M.L.;
- Till, B.G.;
- Park, S.I.;
- Morschhauser, F.;
- Cartron, G.;
- Marks, R.;
- Penuel, E.;
- Chitra, S.;
- Kuhn, M.;
- Popplewell, L.
Publication type:
Article
A PHASE I STUDY OF UTOMILUMAB (PF-05082566), A 4-1BB/CD137 AGONIST, IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH CD20<sup>+</sup> NON-HODGKIN'S LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 260, doi. 10.1002/hon.2438_127
By:
- Gopal, A.;
- Levy, R.;
- Houot, R.;
- Patel, S.;
- Hatake, K.;
- Popplewell, L.;
- Chen, Y.;
- Davis, C.;
- Huang, B.;
- Cesari, R.;
- Thall, A.;
- Woolfson, A.;
- Bartlett, N.
Publication type:
Article
A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806.
Published in:
American Journal of Hematology, 2018, v. 93, n. 4, p. 486, doi. 10.1002/ajh.25010
By:
- Persky, Daniel O.;
- Li, Hongli;
- Rimsza, Lisa M.;
- Barr, Paul M.;
- Popplewell, Leslie L.;
- Bane, Charles L.;
- Von Gehr, Ann;
- LeBlanc, Michael;
- Fisher, Richard I.;
- Smith, Sonali M.;
- Friedberg, Jonathan W.
Publication type:
Article
Oral complications of cancer and cancer therapy: From cancer treatment to survivorship.
Published in:
2012
By:
- Epstein JB;
- Thariat J;
- Bensadoun RJ;
- Barasch A;
- Murphy BA;
- Kolnick L;
- Popplewell L;
- Maghami E
Publication type:
Journal Article

Found: 42